Second Sight rises on shareholder approval for merger deal

Vivani Medical

29/07/2022 12:46

** Shares of visual prosthetics developer Second Sight
Medical Products  EYES.O  rise 4.8% to $1.99 premarket
    ** Co's shareholders approve proposed merger with Nano
Precision Medical (NPM)  urn:newsml:reuters.com:*:nBw98Cd4Va
    ** In February, EYES said it would merge with privately held
NPM in an all-stock deal  urn:newsml:reuters.com:*:nL1N2UJ10C
    ** Co expects merger to complete in latter part of August
    ** Shareholders also approve amendment to change name of
Second Sight to Vivani Medical Inc
    ** Stock has gained 12.88% this year, as of last close

 (Reporting by Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com;))